{
  "ticker": "MDR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964927",
  "id": "02964927",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250702",
  "time": "0938",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250702/pdf/06lcknflnd7374.pdf",
  "summary": "### Sale of ANZ Business Operations Update (MedAdvisor Limited \u2013 ASX: MDR)  \n\n**Key Material Information:**  \n- **Transaction Structure**: Sale of ANZ business (MedAdvisor International Pty Ltd, Medicines Information Pty Ltd, UK investment in Charac, and related IP) to Jonas Software AUS Pty Ltd.  \n- **Total Consideration**:  \n  - **Upfront**: $35M (headline price), with $27M payable at completion (after $8M holdback for working capital adjustments).  \n  - **Earn-Out**: Uncapped 3-year performance-based contingent payment (estimated at $7.35M if targets met).  \n- **Debt Repayment**: ~$23.5M to fully discharge Partners For Growth facility from upfront proceeds.  \n- **US Operations**: Retained under royalty-free license; company rebranding post-sale (subject to shareholder approval).  \n- **Target Completion Date**: 8 July 2025.  \n\n**Other Material Impacts**:  \n- Post-transaction cash position to fund US strategic review; potential capital return to shareholders (timing/quantum uncertain pending holdback/earn-out).  \n\n**Omitted**: Forward-looking statements, vendor background, routine operational details.  \n\n*Rule Applied: \"Other Announcement\" \u2013 focused on valuation/liquidity/capital structure impacts.*",
  "usage": {
    "prompt_tokens": 1701,
    "completion_tokens": 282,
    "total_tokens": 1983,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-01T23:42:35.224509"
}